Biogen Pushes Ahead With Aduhelm Confirmatory Trial As CMS Final Decision Looms

Biogen interim head of R&D Priya Singhal talked to the Pink Sheet about ramping up the Phase IV trial for Aduhelm, the CMS coverage determination and taking over R&D at a challenging time for the company.